Results 11 to 20 of about 382,917 (208)

The shifting nature of women’s experiences and perceptions of ductal carcinoma in situ [PDF]

open access: yes, 2011
Aim: This paper is a report of a descriptive qualitative study of the evolution of women’s perceptions and experiences of ductal carcinoma in situ from the period near to diagnosis to one year later.
Baum   +51 more
core   +1 more source

Using of Binominal Method for the Purpose of Determination of Confidence Intervals for Prediction of Invasive Ductal Breast Carcinoma Metastases [PDF]

open access: yes, 2016
The study was performed using surgical and biopsy material based on histopathological study, which was conducted at the Chernivtsy Regional Clinical Oncology Centre.
Davydenko, I. (Igor)   +1 more
core   +2 more sources

Invasive ductal carcinoma ex pleomorphic adenoma of the lacrimal gland - a long term follow-up case

open access: yesHuman Pathology: Case Reports, 2017
We experienced a case of malignant orbital tumor in a 72-year-old Japanese man. He noticed protrusion of his left eye, and received resection of the left orbital tumor.
Naoko Nambu   +7 more
doaj   +1 more source

Clinical-pathological features of an occult mixed mucinous male breast cancer. a case report [PDF]

open access: yes, 2017
Mucinous carcinoma of the male breast is an uncommon malignant breast neoplasm and its diagnoses remain difficult. It is probably due to such a low rate of breast cancer cases that men tend to be diagnosed at an older age than women and with a later ...
Bonifacino, Adriana   +7 more
core   +1 more source

Invasive Lobular Carcinoma of the Breast with Extracellular Mucin- A New Rare Variant [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2015
Historically, extracellular mucin secretion is by default a feature of ductal carcinoma. Lobular carcinoma is known to be associated with only intracytoplasmic mucin production and signet ring cells.
Vaibhav Bhika Bari   +2 more
doaj   +1 more source

Evaluation of a Novel Anti-Mucin 1 (MUC1) Antibody (PankoMab) as a Potential Diagnostic Tool in Human Ductal Breast Cancer; Comparison with Two Established Antibodies [PDF]

open access: yes, 2009
Aim: PankoMab is a novel antibody that recognizes a tumor-specific epitope of Mucin 1 (MUC1). The aim of this study was the evaluation of PankoMab as a potential diagnostic tool and its comparison with two established antibodies against MUC1 in human ...
Dian, Darius   +7 more
core   +1 more source

Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast

open access: yesBreast Cancer Research, 2020
The immune microenvironment in ductal carcinoma in situ (DCIS) and its significance are not well established. This study was conducted to evaluate the immune microenvironment of DCIS including the composition of tumor-infiltrating lymphocyte (TIL ...
Milim Kim   +5 more
semanticscholar   +1 more source

Unusual Metastasis of Lobular Carcinoma of the Breast

open access: yesHaseki Tıp Bülteni, 2018
Invasive lobular carcinoma is the second most common type of invasive breast cancer accounting for approximately 5-10% of all invasive breast carcinomas. The metastatic patterns of lobular and ductal carcinomas are significantly different.
Songül Peltek Özer, Saime Gül Barut
doaj   +1 more source

The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal carcinoma of the breast: a National Cancer Database Study

open access: yesnpj Breast Cancer, 2021
When molecular testing classifies breast tumors as low risk but clinical risk is high, the optimal management strategy is unknown. One group of patients who may be more likely to have such discordant risk are those with invasive lobular carcinoma of the ...
Mary Kathryn Abel   +8 more
doaj   +1 more source

The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinoma [PDF]

open access: yes, 2007
Aims: To clarify MUC1 patterns in invasive ductal breast carcinoma and to relate them to clinicopathological parameters, coexpression of other biological markers and prognosis.
Arnerlov C   +10 more
core   +2 more sources

Home - About - Disclaimer - Privacy